#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Emphysema Congenital disorder of glycosylation Activated PI3 kinase delta syndrome Uveal melanoma Cutaneous T-cell lymphoma recurrent Extra-osseous Ewing's sarcoma metastatic Marginal zone lymphoma refractory Acute graft versus host disease Acute graft versus host disease in liver Eosinophilic granulomatosis with polyangiitis Asthma Gastrooesophageal cancer Hodgkin's disease refractory Thymic carcinoma Cholestatic pruritus More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Basic Information Idiopathic inflammatory myopathy – Basic Information Congenital hypotransferrinaemia – Treatment Progressive multifocal leukoencephalopathy – Basic Information Prader-Willi syndrome – Diagnostics Adrenogenital syndrome – Basic Information Atypical haemolytic uraemic syndrome – Trials in Disease Aicardi-Goutieres syndrome – Treatment Haemolytic uraemic syndrome – Diagnostics Fabry’s disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ethambutol Autologous Microfat Olaparib Omp66 Gs-5245 Msv/As Ponatinib Dl-Alpha Tocopherol Acetate Nebivolol Hydrochloride Lepidoglyphus Destructor Methyl Aminolevulinate Ace Inhibitors, Plain Rozanolixizumab Bms-986315 SAR443820 Isaralgagene Civaparvovec Prednisolone Sar-443579 Bimekizumab Petrelintide More therapies…

    Learn about Your Condition

    Rubella Neurodegenerative disorder Mucopolysaccharidosis III Friedreich's ataxia Aortic aneurysm Dermatitis Bacterial infection Palpitations Encephalopathy neonatal Nocturia Bladder cancer Postprandial hypoglycaemia Pulmonary fibrosis Sickle cell disease Cervical dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Long-term Safety and Efficacy Study of Gene Therapy for Choroideremia and X-Linked Retinitis Pigmentosa Using AAV2-REP1 and AAV8-RPGR in Previously Treated Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Choroidal dystrophy
    • Retinitis pigmentosa
    Investigated Drugs:
    • Timrepigene Emparvovec
    France Germany

  • Long-Term Study on Aflibercept for Retinopathy of Prematurity in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Aflibercept
    Bulgaria Romania

  • Study on the Effects of Bosentan for Patients with Early Stage Non-Arteritic Anterior Ischemic Optic Neuropathy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Optic ischaemic neuropathy
    Investigated Drugs:
    • Bosentan
    France

  • Study on the Effects of Atropine Sulfate Monohydrate Eye Drops in Slowing Myopia Progression in Children

    Not recruiting

    3 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate Monohydrate
    Czechia

  • Study on the Safety and Effectiveness of Nerve Growth Factor CHF6467 for Children and Young Adults with Optic Pathway Glioma

    Not recruiting

    1 1
    Investigated Diseases:
    • Optic glioma
    Investigated Drugs:
    • Nerve Growth Factor, Recombinant (R100E)
    Italy

  • Study on Bevacizumab Injections for Patients with Coats’ Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Exudative retinopathy
    Investigated Drugs:
    • Bevacizumab
    France
Previous Page
1 … 24 25 26 27 28 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!